World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02364154
Date of registration: 10/02/2015
Prospective Registration: No
Primary sponsor: Hasselt University
Public title: Colorectal Cancer Detected by 1H-NMR Spectroscopy BIOCOR
Scientific title: Metabolic Phenotyping of Blood Plasma by Means of 1H-NMR Spectroscopy: a New Tool to Detect Colorectal Cancer?
Date of first enrolment: December 2014
Target sample size: 100
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02364154
Study type:  Observational [Patient Registry]
Study design:   
Phase: 
Countries of recruitment
Belgium
Contacts
Name:     Philip Caenepeel, prof. dr.
Address: 
Telephone:
Email:
Affiliation:  Ziekenhuis Oost-Limburg, Hasselt University
Name:     Robby Louis, student
Address: 
Telephone:
Email:
Affiliation:  Hasselt University
Name:     Liesbet Mesotten, prof. dr.
Address: 
Telephone:
Email:
Affiliation:  Ziekenhuis Oost-Limburg, Hasselt University
Name:     Michiel thomeer, prof. dr.
Address: 
Telephone:
Email:
Affiliation:  Ziekenhuis Oost-Limburg, Hasselt University
Name:     Evelyne Louis, PhD student
Address: 
Telephone:
Email:
Affiliation:  Hasselt University
Name:     Kirsten Stinkens, dr.
Address: 
Telephone:
Email:
Affiliation:  Hasselt University
Name:     Peter Adriaensens, prof. dr.
Address: 
Telephone:
Email:
Affiliation:  Hasselt University
Key inclusion & exclusion criteria

Inclusion Criteria:

- The subject has undergone a colonoscopy or is scheduled to undergo a colonoscopy in
the future

- The subject is aged between 40 and 90 years

- The subject understands the study-specific procedures and provides written informed
consent before any study-specific procedures are performed

Exclusion Criteria:

- No fasting starting from 10 p.m. the day prior to blood sampling

- Medication intake on the morning of blood sampling

- Diabetes

- History of cancer during the past 5 years

- Treatment for cancer during the past 5 years

- Inflammatory bowel disease



Age minimum: 40 Years
Age maximum: 90 Years
Gender: All
Health Condition(s) or Problem(s) studied
Colorectal Cancer
Intervention(s)
Other: Blood sampling
Other: Control group-Blood sampling
Primary Outcome(s)
metabolic phenotype of colorectal cancer [Time Frame: day 1]
Secondary Outcome(s)
tumor stage [Time Frame: Day 1]
tumor histology [Time Frame: day 1]
Secondary ID(s)
14/070U
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ziekenhuis Oost-Limburg
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history